See also this year's filing and all EDGAR filings for this company.
PDF Report 0001175505_2020_FIVE_Prime_Therapeutics_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001175505, FIVE Prime Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 166,720,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 22,534,000 |
| 3 | remainder_Assets | 34,888,000 |
| 4 | LiabilitiesCurrent | 23,024,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 43,141,127 |
| 9 | ResearchAndDevelopmentExpense | 80,351,595 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 31,759,707 |
| 12 | remainder_NetIncome | 4,735,242 |
| 13 | remainder_ComprehensiveNetIncome | 262,434 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 224,142,000 |
| 1 | Liabilities | 23,024,000 |
| 2 | Expenses | 123,492,722 |
| 3 | Revenues | 31,759,707 |
| 4 | StockholdersEquity | 201,118,000 |
| 5 | NetIncome | -86,997,773 |
| 6 | ComprehensiveNetIncome | -86,866,556 |
| 7 | BaseVar | 203,708,052 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.84 |
| 9 | EconomicCapitalRatio | 3.58 |
Edgar->Model Mapping
Feature Distribution
Change over Time
